104 related articles for article (PubMed ID: 6587344)
1. Potential use of biaromatic L-phenylalanyl derivatives as therapeutic agents in the treatment of sickle cell disease.
Votano JR; Altman J; Wilchek M; Gorecki M; Rich A
Proc Natl Acad Sci U S A; 1984 May; 81(10):3190-4. PubMed ID: 6587344
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of pyridine derivatives of L-phenylalanine as antisickling reagents.
Altman J; Gorecki M; Wilchek M; Votano JR; Rich A
J Med Chem; 1984 May; 27(5):596-600. PubMed ID: 6716398
[TBL] [Abstract][Full Text] [Related]
3. The effect of phenylalanine derivatives on the solubility of deoxyhemoglobin S. A model class of gelation inhibitors.
Noguchi CT; Ackerman S; DiMaio J; Schiller PW; Schechter AN
Mol Pharmacol; 1983 Jan; 23(1):100-3. PubMed ID: 6865893
[TBL] [Abstract][Full Text] [Related]
4. Non-uniformity of intracellular polymer formation in sickle erythrocytes: possible correlation with severity of hemolytic anemia.
Noguchi CT; Schechter AN
Am J Pediatr Hematol Oncol; 1984; 6(1):46-50. PubMed ID: 6711762
[TBL] [Abstract][Full Text] [Related]
5. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
Noguchi CT; Rodgers GP; Schechter AN
Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
[TBL] [Abstract][Full Text] [Related]
6. Mode of transport and possible mechanism of action of L-phenylalanine benzyl ester as an anti-sickling agent.
Acquaye CT; Young JD; Ellory JC; Gorecki M; Wilchek M
Biochim Biophys Acta; 1982 Dec; 693(2):407-16. PubMed ID: 7159585
[TBL] [Abstract][Full Text] [Related]
7. Intracellular polymerization. Disease severity and therapeutic predictions.
Noguchi CT; Rodgers GP; Schechter AN
Ann N Y Acad Sci; 1989; 565():75-82. PubMed ID: 2476066
[TBL] [Abstract][Full Text] [Related]
8. Oxidative process in erythrocytes of individuals with hemoglobin S.
Chaves MA; Leonart MS; do Nascimento AJ
Hematology; 2008 Jun; 13(3):187-92. PubMed ID: 18702879
[TBL] [Abstract][Full Text] [Related]
9. The treatment of sickle cell anemia with induced hyponatremia.
Rosa RM; Bierer BE; Bunn HF; Epstein FH
Blood Cells; 1982; 8(2):329-35. PubMed ID: 7159756
[TBL] [Abstract][Full Text] [Related]
10. Polymerization of sickle cell hemoglobin at arterial oxygen saturation impairs erythrocyte deformability.
Green MA; Noguchi CT; Keidan AJ; Marwah SS; Stuart J
J Clin Invest; 1988 Jun; 81(6):1669-74. PubMed ID: 3384944
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study of erythrocyte density in sickle cell disease patients.
Ilboudo Y; Bartolucci P; Rivera A; Sedzro JC; Beaudoin M; Trudel M; Alper SL; Brugnara C; Galactéros F; Lettre G
Blood Cells Mol Dis; 2017 Jun; 65():60-65. PubMed ID: 28552477
[TBL] [Abstract][Full Text] [Related]
12. Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease.
De Franceschi L; Saadane N; Trudel M; Alper SL; Brugnara C; Beuzard Y
J Clin Invest; 1994 Apr; 93(4):1670-6. PubMed ID: 7512989
[TBL] [Abstract][Full Text] [Related]
13. New antisickling agents.
Labie D
Haematologia (Budap); 1983; 16(1-4):105-8. PubMed ID: 6679483
[TBL] [Abstract][Full Text] [Related]
14. Liposome-loaded phenylalanine or tryptophan as sickling inhibitor: a possible therapy for sickle cell disease.
Kumpati J
Biochem Med Metab Biol; 1987 Oct; 38(2):170-81. PubMed ID: 3675919
[TBL] [Abstract][Full Text] [Related]
15. Mean corpuscular hemoglobin concentration and cell deformability.
Clark MR
Ann N Y Acad Sci; 1989; 565():284-94. PubMed ID: 2672965
[TBL] [Abstract][Full Text] [Related]
16. Binding of a spin-labeled phenylalanine analog to sickle hemoglobin: EPR and NMR studies.
Lu HZ; Currie BL; Johnson ME
FEBS Lett; 1984 Jul; 173(1):259-63. PubMed ID: 6086399
[TBL] [Abstract][Full Text] [Related]
17. Contributions of sickle hemoglobin polymer and sickle cell membranes to impaired filterability.
Hiruma H; Noguchi CT; Uyesaka N; Schechter AN; Rodgers GP
Am J Physiol; 1995 May; 268(5 Pt 2):H2003-8. PubMed ID: 7771550
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte Hb-S concentration. An important factor in the low oxygen affinity of blood in sickle cell anemia.
Seakins M; Gibbs WN; Milner PF; Bertles JF
J Clin Invest; 1973 Feb; 52(2):422-32. PubMed ID: 4683881
[TBL] [Abstract][Full Text] [Related]
19. Arginine supplementation of sickle transgenic mice reduces red cell density and Gardos channel activity.
Romero JR; Suzuka SM; Nagel RL; Fabry ME
Blood; 2002 Feb; 99(4):1103-8. PubMed ID: 11830454
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of filterability of sickle cells by cyanate: an effect independent of oxygen saturation.
Wagner SM; Bishop J; Flanigan PW; Bromberg PA; Balcerzak SP
J Lab Clin Med; 1975 Mar; 85(3):445-50. PubMed ID: 1117207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
